Literature DB >> 23188860

Heparin-induced thrombocytopenia associated with acute liver graft failure.

Nadine Pannicke1, Joerg-Matthias Pollok, Stefan Kluge, Martin Petzoldt.   

Abstract

An orthotopic liver transplantation (OLT) is of a proven benefit in an acute liver failure (ALF). Heparin-induced thrombocytopenia (HIT) is strongly associated with thromboembolic complications. We present the case of a 56-year-old patient who underwent an OLT owing to an ALF of unknown aetiology. HIT type II with consecutive hepatic and portal vein thrombosis caused progressive graft failure. Total hepatectomy and porto-caval shunt were performed to reduce the toxic effects of liver cell necrosis such as multiorgan failure involving the respiratory, renal and cardiovascular systems. A suitable liver graft was allocated after an anhepatic bridging period of 56 h. Specific complications due to end-stage liver failure-such as acidosis, coagulopathy, decrease of vascular resistance, cerebral oedema, myocardial infarction and right heart failure-were treated. Following a re-OLT, the patient made a complete recovery. We present a rare case of HIT-associated early liver graft failure followed by a prolonged anhepatic phase and finally a successful re-OLT.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23188860      PMCID: PMC4543999          DOI: 10.1136/bcr-2012-007323

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

Review 1.  Artificial and bioartificial support systems for liver failure.

Authors:  J P Liu; L L Gluud; B Als-Nielsen; C Gluud
Journal:  Cochrane Database Syst Rev       Date:  2004

2.  Long-term survival after 67 hours of anhepatic state due to primary liver allograft nonfunction.

Authors:  Harendra Arora; Janine Thekkekandam; Leora Tesche; Raeshell Sweeting; David A Gerber; Paul H Hayashi; Kenneth Andreoni; Tomasz Kozlowski
Journal:  Liver Transpl       Date:  2010-12       Impact factor: 5.799

3.  Argatroban therapy in heparin-induced thrombocytopenia with hepatic dysfunction.

Authors:  Robert L Levine; Marcie J Hursting; David McCollum
Journal:  Chest       Date:  2006-05       Impact factor: 9.410

4.  The "white clot syndrome" in hepatic transplantation.

Authors:  T A Broughan; K Kottke-Marchant; D P Vogt
Journal:  Transplantation       Date:  1996-03-27       Impact factor: 4.939

5.  First workshop for detection of heparin-induced antibodies: validation of the heparin-induced platelet-activation test (HIPA) in comparison with a PF4/heparin ELISA.

Authors:  P Eichler; U Budde; S Haas; H Kroll; R M Loreth; O Meyer; U Pachmann; B Pötzsch; A Schabel; D Albrecht; A Greinacher
Journal:  Thromb Haemost       Date:  1999-04       Impact factor: 5.249

6.  Noninvasive monitoring of cerebral perfusion pressure in patients with acute liver failure using transcranial doppler ultrasonography.

Authors:  Shushma Aggarwal; David M Brooks; Yoogoo Kang; Peter K Linden; John F Patzer
Journal:  Liver Transpl       Date:  2008-07       Impact factor: 5.799

7.  Heparin-induced thrombocytopenia after liver transplantation.

Authors:  J Kaneko; Y Sugawara; S Tamura; J Togashi; Y Matsui; M Makuuchi
Journal:  Transplant Proc       Date:  2008-06       Impact factor: 1.066

Review 8.  Drugs for the prevention and treatment of thrombosis in patients with heparin-induced thrombocytopenia.

Authors:  N Lubenow; A Greinacher
Journal:  Am J Cardiovasc Drugs       Date:  2001       Impact factor: 3.571

9.  Artificial liver support molecular adsorbents recirculating system therapy as a bridge to re-transplantation in two cases of long anhepatic duration.

Authors:  Yi-He Liu; Yu Wang; Li-Xin Yu; Li-Ying Sun; Bao-Lan Feng; Zhong-Yang Shen; Min-Min Wang
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2004-05

10.  Two-stage liver transplantation: an effective procedure in urgent conditions.

Authors:  Roberto Montalti; Stefano Busani; Michele Masetti; Massimo Girardis; Fabrizio Di Benedetto; Bruno Begliomini; Gianluca Rompianesi; Laura Rinaldi; Roberto Ballarin; Alberto Pasetto; Giorgio E Gerunda
Journal:  Clin Transplant       Date:  2009-10-15       Impact factor: 2.863

View more
  2 in total

1.  A Case Report of Drug-Induced Thrombocytopenia after Living Donor Liver Transplantation.

Authors:  Keisuke Arai; Kaori Kuramitsu; Takumi Fukumoto; Masahiro Kido; Atsushi Takebe; Motofumi Tanaka; Hisoka Kinoshita; Tetsuo Ajiki; Hirochika Toyama; Sadaki Asari; Tadahiro Goto; Yonson Ku
Journal:  Kobe J Med Sci       Date:  2016-06-16

Review 2.  Thrombocytopenia after liver transplantation: Should we care?

Authors:  Kazuhiro Takahashi; Shunji Nagai; Mohamed Safwan; Chen Liang; Nobuhiro Ohkohchi
Journal:  World J Gastroenterol       Date:  2018-04-07       Impact factor: 5.742

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.